Ruxuan Chen

Peking Union Medical College Hospital, Peking Union Medical College
Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications

Clinical characteristics and risk factors of cytomegalovirus infection in patients with good syndrome.

Clinical characteristics and risk factors of cytomegalovirus infection in patients with good syndrome.

Journal: BMC immunology
Published: May 14, 2026

68Ga-FAPI PET/CT features of thoracic sarcoidosis: a prospective observational study.

68Ga-FAPI PET/CT features of thoracic sarcoidosis: a prospective observational study.

Journal: BMC pulmonary medicine
Published: March 30, 2026

Kv1.3 modulates macrophage M2 polarization via the STAT3 pathway: A novel mechanism and therapeutic target for steroid-resistant asthma.

Kv1.3 modulates macrophage M2 polarization via the STAT3 pathway: A novel mechanism and therapeutic target for steroid-resistant asthma.

Journal: Translational research : the journal of laboratory and clinical medicine
Published: March 11, 2026

Authoritative Textbook-Augmented Large Language Models for High-Altitude Public Health Medical Education in the Xizang Autonomous Region: Cross-Sectional Comparative Evaluation Study.

Authoritative Textbook-Augmented Large Language Models for High-Altitude Public Health Medical Education in the Xizang Autonomous Region: Cross-Sectional Comparative Evaluation Study.

Journal: Journal of medical Internet research
Published: February 04, 2026

Copanlisib ameliorates pulmonary fibrosis by modulating cellular autophagy through PI3K/Akt/mTORC1 pathway.

Copanlisib ameliorates pulmonary fibrosis by modulating cellular autophagy through PI3K/Akt/mTORC1 pathway.

Journal: Journal of thoracic disease
Published: January 13, 2026

Phase-engineered 1T'/2H-MoS2 heterophase junctions for high-performance aqueous zinc-ion batteries.

Phase-engineered 1T'/2H-MoS2 heterophase junctions for high-performance aqueous zinc-ion batteries.

Journal: Nanoscale
Published: December 23, 2025

Repurposing the MEK inhibitor binimetinib as a dual anti-inflammatory and antifibrotic agent in pulmonary fibrosis.

Repurposing the MEK inhibitor binimetinib as a dual anti-inflammatory and antifibrotic agent in pulmonary fibrosis.

Journal: Journal of thoracic disease
Published: December 21, 2025

Efficacy of antifibrotic treatment for ANCA-positive fibrosing interstitial lung disease: a retrospective case‒control study.

Efficacy of antifibrotic treatment for ANCA-positive fibrosing interstitial lung disease: a retrospective case‒control study.

Journal: BMC pulmonary medicine
Published: October 12, 2025

Nerandomilast attenuates Pantoea agglomerans-induced hypersensitivity pneumonitis by regulating M1 macrophage polarization and fibroblast activation.

Nerandomilast attenuates Pantoea agglomerans-induced hypersensitivity pneumonitis by regulating M1 macrophage polarization and fibroblast activation.

Journal: Respiratory research
Published: October 07, 2025

Clinical analysis of eight patients with lung biopsy-proven pulmonary intravascular large B-cell lymphoma in a single center.

Clinical analysis of eight patients with lung biopsy-proven pulmonary intravascular large B-cell lymphoma in a single center.

Journal: Hematology (Amsterdam, Netherlands)
Published: October 03, 2025

A case report of idiopathic pulmonary fibrosis concurrent with EGFR 19 deletion lung adenocarcinoma.

A case report of idiopathic pulmonary fibrosis concurrent with EGFR 19 deletion lung adenocarcinoma.

Journal: Translational cancer research
Published: October 01, 2025

Crizotinib attenuates bleomycin-induced pulmonary fibrosis via regulating fibroblast activation.

Crizotinib attenuates bleomycin-induced pulmonary fibrosis via regulating fibroblast activation.

Journal: Journal of thoracic disease
Published: August 22, 2025
Showing 1-12 of 45

Last Updated: 09/26/2026